Skip to main content
logo
City Therapeutics, Inc. (CTY)
NASDAQ: CTY · Real-Time Price · USD
22.40
+4.40 (24.44%)
At close: Oct 16, 2026, 4:00 PM EDT
22.15
-0.25 (-1.12%)
After-hours: Oct 16, 2026, 7:58 PM EDT

City Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Market Capitalization
1,115--
Market Cap Growth
---
Enterprise Value
1,002--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Debt / Equity Ratio
0.461.120.19
Net Debt / Equity Ratio
-0.90-0.76-0.91
Net Debt / EBITDA Ratio
1.360.783.65
Net Debt / FCF Ratio
1.391.034.37
Asset Turnover
-0.09-
Quick Ratio
2.703.006.18
Current Ratio
2.713.076.22
Return on Equity (ROE)
--66.88%-
Return on Assets (ROA)
--25.38%-
Return on Capital Employed (ROCE)
-58.70%-53.60%-23.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Buyback Yield / Dilution
--37.97%-
SEC Filings: 10-K · 10-Q